Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

CTnI/MYO/CK-MB Overview

The isoenzyme troponin I/myoglobin/creatine kinase (cTnI/Myo/CK-MB) includes the following three indicators: The combined detection of troponin I (cTnI), myoglobin (Myo) and creatine kinase isoenzyme (CK-MB) is of great importance for the Early diagnosis of acute myocardial diseases such as AMI

American Society for Clinical Biochemistry ( NACB ) Practice Guide

Signs of myocardial necrosis should be detected in all patients with ACS
Troponin is a key marker in the diagnosis of myocardial infarction
Myoglobin binding specific markers of myocardial necrosis (eg, cTnI/CK-MB) may help clear or diagnose myocardial infarction more quickly.

cTnI/MYO/CK-MB Performance Index

CTnI/MYO/CK-MB Clinical Significance

• This is for the initial and strategic diagnosis of corneal syndrome risk
• Defining the area of myocardial infarction
• Different diagnosis of different causes of chest pain
• Beware of myocardial injury for a variety of reasons
• Evaluation of clinical evidence of some medical drugs

Application Department

Emergency outpatient departments, Cardiovascular Examination Centers, ICUs and Chest Pain Centers

CTnI/MYO/CK-MB Clinical Comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.